RxDoctor Payments Data

Lisa Novak

Psychiatric/Mental Health · Yonkers, NYNPI 1124329537

Payments from drug & device makers

$2,735in general payments, 2019–2025

Across 136 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$928
  • Otsuka America Pharmaceutical, Inc.$417
  • Bausch Health US, LLC$312
  • AbbVie$285
  • Takeda Pharmaceuticals U.S.A., Inc.$236
  • Alfasigma USA, Inc.$159
  • plus $399 from 6 others

What the payments were for

  • Food & beverage$2,735100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,735 in reported general payments places this provider in the 80th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$26,323
Medicare patients
30
Services billed
318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole29$78,870
MounjaroTirzepatide17$26,286
LexaproEscitalopram Oxalate13$16,056
TrintellixVortioxetine Hydrobromide15$15,160
VraylarCariprazine Hcl11$14,407
PristiqDesvenlafaxine Succinate18$7,936
Topiramate ErTopiramate12$5,328
Ramelteon34$4,360
MydayisDextroamphetamine/Amphetamine11$3,405
Duloxetine Hcl14$1,492
Vilazodone Hcl12$1,042
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$597
Lorazepam33$521
Clonazepam39$504
Sertraline Hcl30$470

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$417$78,87029 claims
AbbVieLexapro, Vraylar$285$30,46324 claims
Lilly USA, LLCMounjaro$62$26,28617 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$236$15,16015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Yonkers

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →